Skip to content
healthcare.dev

Naproxen

NDC 90096-161, Naproxen, tablet, delayed release, from Zameer Pharmaceuticals LLC.

Product NDC
90096-161
Status
Listed
Labeler
Zameer Pharmaceuticals LLC
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA020067
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/90096-161 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN500 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
90096-161-0190096016101100 TABLET, DELAYED RELEASE in 1 BOTTLE (90096-161-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d2e5553a-7c90-407c-9f07-3be65560c23a
  • NADAC price for package 90096016101

    GET /v1/drugs/nadac/90096016101

Use it

Look up 90096-161 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/90096-161 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 90096-161. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.